Company led recall: Mydriasert 0.28mg/5.4mg Ophthalmic Insert

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for a specific batch of Mydriasert 0.28mg/5.4mg Ophthalmic Insert (Thea Pharmaceuticals) as it is labelled as being for the French market, rather than the UK market.
 

Further details of the recall, the affected batch, and actions to take are available on the MHRA website.